|
Index of reports
> Serious Reactions (2508)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cyclophosphamide serious reactions. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 2508 Next >>
Possible Cyclophosphamide side effects in 47 year old male
Reported by a physician from France on 2012-08-27
Patient: 47 year old male
Reactions: Respiratory Tract Infection Bacterial, Epstein-Barr Virus Associated Lymphoma, Congestive Cardiomyopathy, Systolic Dysfunction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-06-08
Doxorubicin HCL
Start date: 2012-06-11
End date: 2012-07-10
Mabthera
Start date: 2012-06-11
Nexium
Administration route: Oral
Prednisolone
Administration route: Oral
Start date: 2012-06-08
Vincristine
Start date: 2012-06-08
Other drugs received by patient: Previscan; Methotrexate Sodium; Potassium Chloride; Kineret; Kineret; Kineret; Cacit D3; Aspirin; Prednisone TAB; Acetaminophen; Acetaminophen W / Codeine; Alendronate Sodium / Cholecalciferol
Possible Cyclophosphamide side effects in 57 year old female
Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-08-27
Patient: 57 year old female
Reactions: Breast Cancer Metastatic, Paraneoplastic Dermatomyositis, Pulmonary Embolism
Adverse event resulted in: death
Drug(s) suspected as cause:
Capecitabine
Administration route: Oral
Indication: Breast Cancer
Cisplatin
Dosage: 6 cycles
Indication: Breast Cancer
Cyclophosphamide
Dosage: 6 cycles
Indication: Breast Cancer
Doxorubicin Hydrochloride
Dosage: 6 cycles
Indication: Breast Cancer
Gemcitabine Hydrochloride
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Bleomycin Sulfate
Dosage: 10000 iu, day 8 (4 standard cycles)
Cyclophosphamide
Dosage: 650 mg/m2, day 1 (4 standard cycles)
Cyclophosphamide
Dosage: 1250 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2, day 1 (4 standard cycles)
Doxorubicin HCL
Dosage: 35 mg/m2, day 1 (2 escalated cycles)
Indication: Hodgkin's Disease
Etoposide
Dosage: 100 mg/m2, day 1-3 (4 standard cycles)
Etoposide
Dosage: 200 mg/m2, day 1-3 (2 escalated cycles)
Indication: Hodgkin's Disease
Prednisolone
Dosage: 40 mg/m2, day 1-14 (4 standard cycles)
Administration route: Oral
Prednisolone
Dosage: 40 mg/m2, day 1-14 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (2 escalated cycles)
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 100 mg/m2, day 1-7 (4 standard cycles)
Administration route: Oral
Vincristine
Dosage: 1.4 mg/m2, day 8 (2 escalated cycles)
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, day 8 (4 standard cycles)
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-27
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Cyclophosphamide side effects in 62 year old female
Reported by a physician from Spain on 2012-08-27
Patient: 62 year old female
Reactions: Osteonecrosis
Drug(s) suspected as cause:
Anastrozole
Dosage: 1 mg/day
Indication: Breast Cancer
Cyclophosphamide
Dosage: 600 mg/m2 q21d (4 cycles)
Indication: Breast Cancer
Doxorubicin Hydrochloride
Dosage: 60 mg/m2 q21d (4 cycles)
Indication: Breast Cancer
Other drugs received by patient: Dexamethasone; Chlorhexidine Gluconate; Omeprazole
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-27
Patient: male
Reactions: Dystonia, Encephalopathy, Parkinsonism
Drug(s) suspected as cause:
Cisplatin
Cyclophosphamide
Etoposide
Ifosfamide
Vincristine
Possible Cyclophosphamide side effects in
Reported by a physician from Germany on 2012-08-27
Patient:
Reactions: Acute Myeloid Leukaemia
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Fludarabine Phosphate
Indication: Chronic Lymphocytic Leukaemia
Ofatumumab
Indication: Chronic Lymphocytic Leukaemia
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity, Neutropenia, Infection
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Indication: Retinoblastoma
Doxorubicin Hydrochloride
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 121.9 kg (268.2 pounds)
Reactions: Pruritus, Unresponsive To Stimuli, Device Related Infection, Pyrexia, Candidiasis, Abscess Limb, Ventricular Extrasystoles, Metabolic Acidosis, Dyspnoea, Hypotension, Pancytopenia, Tremor, Convulsion, Respiratory Failure, Fungal Infection, Ventricular Tachycardia, Sepsis, Respiratory Arrest, Pulse Absent, Sinus Tachycardia, Hypertension, Feeling Abnormal, Cardiac Arrest, Escherichia Infection, Infusion Related Reaction
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clolar
Dosage: 74.4 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Cyclophosphamide
Dosage: daily for 5 days
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Epinephrine
Dosage: 4 df, unk
Indication: Cardiac Arrest
Start date: 2012-07-14
End date: 2012-07-14
Epinephrine
Dosage: unk
Start date: 2012-07-14
End date: 2012-07-14
Etoposide
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-19
End date: 2012-06-23
Oncaspar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Vincristine Sulfate
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-07-02
End date: 2012-07-02
Other drugs received by patient: Colace; Bactrim; Stomatitis Mouthwash; Prilosec; Lortab; Cymbalta; Ondansetron; Ambien
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-24
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Lung Infiltration, Septic Shock, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Dosage: on day 8
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: for standard cycles on day 1
Doxorubicin Hydrochloride
Dosage: on day 1,for standard cycles
Doxorubicin Hydrochloride
Dosage: for escalated cycles on day 1
Indication: Hodgkin's Disease
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the escalated cycles on day 1 to 3
Etoposide
Dosage: for the standard cycles, day 1 to 3
Indication: Hodgkin's Disease
Prednisolone
Dosage: on day 1 to 14 every 21 day cycle treatment for 6 cycles
Administration route: Oral
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: day 1 to 7
Administration route: Oral
Indication: Hodgkin's Disease
Vincristine
Dosage: on day 8
Indication: Hodgkin's Disease
Possible Cyclophosphamide side effects in 51 year old male
Reported by a physician from Germany on 2012-08-24
Patient: 51 year old male
Reactions: Progressive Multifocal Leukoencephalopathy
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Indication: HIV Infection
Doxorubicin HCL
Indication: HIV Infection
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: HIV Infection
Prednisone
Indication: HIV Infection
Prednisone TAB
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: HIV Infection
Vincristine
Indication: non-Hodgkin's Lymphoma
Possible Cyclophosphamide side effects in female
Reported by a physician from Bulgaria on 2012-08-24
Patient: female, weighing 63.0 kg (138.6 pounds)
Reactions: Circulatory Collapse, Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1000 milligram
Indication: Multiple Myeloma
Start date: 2012-05-23
End date: 2012-05-25
Dexamethasone
Dosage: 40 milligram
Start date: 2012-06-02
End date: 2012-06-05
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Start date: 2012-05-23
End date: 2012-05-26
Dexamethasone
Dosage: 20 milligram
Start date: 2012-05-16
End date: 2012-05-19
Doxorubicin Hydrochloride
Dosage: 80 milligram
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-05-26
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-05-30
End date: 2012-06-07
Vincristine
Dosage: 2 milligram
Indication: Multiple Myeloma
Start date: 2012-05-26
End date: 2012-06-02
Other drugs received by patient: Milgamma; Dopamine HCL; Nexium; Atropine; Sodium Carbonate; Lyrica; Uromithexane; Electrolyte Infusions; Sodium Bicarbonate; Probitor; Tevagrastim
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: male, weighing 103.1 kg (226.8 pounds)
Reactions: Plasmacytosis, Pneumonia, Mouth Haemorrhage, Pseudomonas Infection, Headache, Disease Progression, Death, Mucosal Inflammation, Pleural Effusion, Depressed Level of Consciousness, Abscess, Lethargy, RIB Fracture
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Radiation Therapy NOS
Indication: Multiple Myeloma
Revlimid
Indication: Multiple Myeloma
Thalidomide
Indication: Multiple Myeloma
Velcade
Indication: Multiple Myeloma
Other drugs received by patient: Bendamustine Hydrochloride; Lenalidomide
Possible Cyclophosphamide side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: 52 year old female
Reactions: Tumour Lysis Syndrome, Posterior Reversible Encephalopathy Syndrome, Insomnia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Dosage: at 50% dosage
Dexamethasone
Indication: Premedication
Methylprednisolone Sodium Succinate
Indication: B Precursor Type Acute Leukaemia
Prednisone TAB
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Vincristine
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Other drugs received by patient: Ondansetron; Voriconazole; Morphine Sulfate; Morphine
Possible Cyclophosphamide side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male
Reactions: Chalazion
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2010-09-13
Other drugs received by patient: Bisphosphonates; Doxazosin Mesylate
Possible Cyclophosphamide side effects in female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-08-23
Patient: female, weighing 52.0 kg (114.4 pounds)
Reactions: Graft Versus Host Disease, Staphylococcal Infection, Chills, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 4380 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-11
Other drugs received by patient: Sulfamethoxazole Trimethoprim
Possible Cyclophosphamide side effects in 49 year old male
Reported by a physician from Norway on 2012-08-23
Patient: 49 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Bone Marrow Failure, Pyrexia, Septic Shock, Lung Infiltration
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Baxter 15 000 IE Lyofilisat TIL Injeksjonsv?ske / Infusjonsv?s
Cyclophosphamide
Cyclophosphamide
Doxorubicin Hydrochloride
Doxorubicin Hydrochloride
Etoposide
Etoposide
Prednisolone
Administration route: Oral
Procarbazine Hydrochloride
Administration route: Oral
Vincristine
Possible Cyclophosphamide side effects in 64 year old male
Reported by a physician from Germany on 2012-08-23
Patient: 64 year old male, weighing 87.0 kg (191.4 pounds)
Reactions: Malignant Melanoma in Situ
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2011-08-17
End date: 2011-08-18
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Start date: 2011-05-10
End date: 2011-08-02
Etoposide
Start date: 2011-08-17
End date: 2011-08-19
Lenograstim
Indication: Multiple Myeloma
Start date: 2011-08-21
End date: 2011-08-30
Melphalan Hydrochloride
Indication: Multiple Myeloma
Start date: 2011-09-20
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-05-10
End date: 2011-08-01
Other drugs received by patient: Diltiazem; Omeprazole; Albuterol Sulate; Cotrim DS; Micardis; Loratadine; Diazepam; Aspirin; Acyclovir
Possible Cyclophosphamide side effects in
Reported by a physician from United States on 2012-08-23
Patient:
Reactions: Chalazion
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2009-04-01
End date: 2011-02-10
Other drugs received by patient: Zocor; Aredia; Actonel; Bisphosphonates; Lasix; Multi Vitamin and Mineral + Selenium; Comadin
Possible Cyclophosphamide side effects in 56 year old female
Reported by a physician from United Kingdom on 2012-08-23
Patient: 56 year old female, weighing 86.4 kg (190.1 pounds)
Reactions: Gastrooesophageal Reflux Disease
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Start date: 2012-06-15
Dexamethasone
Start date: 2012-06-15
End date: 2012-06-15
Docetaxel
Start date: 2012-06-15
Epirubicin Hydrochloride
Start date: 2012-06-15
Fluorouracil
Start date: 2012-06-15
Ondansetron
Start date: 2012-06-15
End date: 2012-06-15
Other drugs received by patient: Acetaminophen; Filgrastim; Ibuprofen
Possible Cyclophosphamide side effects in 60 year old female
Reported by a physician from United Kingdom on 2012-08-23
Patient: 60 year old female
Reactions: Night Sweats, Endophthalmitis, Fungal Endocarditis, Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath-1
Indication: Chronic Lymphocytic Leukaemia
Cyclophosphamide
Indication: Chronic Lymphocytic Leukaemia
Fludara
Indication: Chronic Lymphocytic Leukaemia
Mycophenolate Mefetil
Indication: Graft Versus Host Disease
Possible Cyclophosphamide side effects in male
Reported by a consumer/non-health professional from France on 2012-08-23
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Abdominal Pain Lower, Bronchopulmonary Aspergillosis, Prostatitis, Cystitis Haemorrhagic, Human Polyomavirus Infection, Pyrexia, Dysuria, Adenovirus Infection, Pollakiuria
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, 3 times per 1 cycle
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Valganciclovir; Bactrim; Folic Acid; Vfend
Possible Cyclophosphamide side effects in male
Reported by a physician from United States on 2012-08-23
Patient: male
Reactions: Death, Chalazion
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2009-08-13
End date: 2012-01-03
Other drugs received by patient: Bisphosphonates; Travoprost
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: male
Reactions: Phlebitis, Lymphocyte Percentage Decreased, Hydronephrosis, Arterial Thrombosis Limb, Urinary Tract Infection, Cystitis Noninfective, Human Polyomavirus Infection, Prothrombin Time Prolonged, Urethritis, Blood Fibrinogen Increased, Genitourinary Tract Infection, Renal Impairment, Adenovirus Infection, Prostatomegaly, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, first 3 days of each cycle (6 cycles)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, first 3 days of each cycle (6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, first 3 days of each cycle (6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Bactrim; Valganciclovir; Vfend; Folic Acid
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-23
Patient: male
Reactions: Dystonia, Encephalopathy, Parkinsonism
Drug(s) suspected as cause:
Cisplatin
Cyclophosphamide
Etoposide
Ifosfamide
Vincristine
Possible Cyclophosphamide side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-23
Patient: male, weighing 79.0 kg (173.8 pounds)
Reactions: Phlebitis, Hydronephrosis, Adenovirus Infection, Cystitis Haemorrhagic, Human Polyomavirus Infection, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, on first 3 days of each cycle (total 6 cycles)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, on first 3 days of each cycle (total 6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, on first 3 days of each cycle (total 6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Folic Acid; Bactrim; Vfend; Valganciclovir
Possible Cyclophosphamide side effects in
Reported by a physician from Japan on 2012-08-23
Patient:
Reactions: White Blood Cell Count Decreased, Stomatitis, Anaemia, Febrile Neutropenia, Constipation, Neutrophil Count Decreased
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 700 mg, qd
Start date: 2010-10-26
End date: 2010-10-26
Cyclophosphamide
Dosage: 700 mg, qd
Start date: 2010-12-07
End date: 2010-12-07
Cyclophosphamide
Dosage: 700 mg, qd
Start date: 2010-11-16
End date: 2010-11-16
Cyclophosphamide
Dosage: 700 mg, once
Indication: Breast Cancer
Start date: 2010-09-29
End date: 2010-10-29
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-10-27
End date: 2010-10-28
Emend
Dosage: 125 mg, qd
Administration route: Oral
Start date: 2010-12-07
End date: 2010-12-07
Emend
Dosage: 125 mg, once
Administration route: Oral
Indication: Prophylaxis of Nausea and Vomiting
Start date: 2010-09-29
End date: 2010-09-29
Emend
Dosage: 125 mg, qd
Administration route: Oral
Start date: 2010-10-26
End date: 2010-10-26
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-09-30
End date: 2010-10-01
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-12-08
End date: 2010-12-09
Emend
Dosage: 80 mg, qd
Administration route: Oral
Start date: 2010-11-17
End date: 2010-11-18
Emend
Dosage: 125 mg, qd
Administration route: Oral
Start date: 2010-11-16
End date: 2010-11-16
Epirubicin Hydrochloride
Dosage: |100 mg, once
Indication: Breast Cancer
Start date: 2010-09-29
End date: 2010-09-29
Epirubicin Hydrochloride
Dosage: 100 mg, qd
Start date: 2010-12-07
End date: 2010-12-07
Epirubicin Hydrochloride
Dosage: 100 mg, qd
Start date: 2010-10-26
End date: 2010-10-26
Epirubicin Hydrochloride
Dosage: 100 mg, qd
Start date: 2010-11-16
End date: 2010-11-16
Other drugs received by patient: Granisetron Hydrochloride; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Dexamethasone Sodium Phosphate; Mucosta; Decadron Phosphate; Granisetron Hydrochloride; Mucosta; Mucosta; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate; Granisetron Hydrochloride; Decadron Phosphate; Dexamethasone Sodium Phosphate
Possible Cyclophosphamide side effects in female
Reported by a health professional (non-physician/pharmacist) from China on 2012-08-23
Patient: female, weighing 50.0 kg (110.0 pounds)
Reactions: Hepatic Function Abnormal
Drug(s) suspected as cause:
Cyclophosphamide
Indication: B-Cell Lymphoma
Start date: 2010-08-25
Mabthera
Indication: B-Cell Lymphoma
Start date: 2010-08-25
Pirarubicin
Indication: B-Cell Lymphoma
Start date: 2010-08-25
Possible Cyclophosphamide side effects in female
Reported by a physician from United States on 2012-08-23
Patient: female
Reactions: Chalazion
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Indication: Multiple Myeloma
Velcade
Dosage: 2 mg, 1/week
Indication: Multiple Myeloma
Start date: 2008-11-13
Other drugs received by patient: Synthroid; Bisphosphonates
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient:
Reactions: Off Label Use, Gastrointestinal Toxicity
Drug(s) suspected as cause:
Carboplatin
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Cyclophosphamide
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Doxorubicin HCL
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Etoposide
Dosage: 6 courses in high risk
Indication: Retinoblastoma
Vincristine
Dosage: 4 courses in intermediate risk and 6 courses in high risk
Indication: Retinoblastoma
Other drugs received by patient: Neupogen
Page 1 Next >>
|
